Want obesity drugs covered by insurance? Telehealth companies have a big say
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Want obesity drugs covered by insurance? Telehealth companies have a big say" is generating significant coverage in the Business category, with 2 articles from 2 distinct sources tracked by PULSE so far.
Outlets currently covering the story include NewsNation and NPR. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 109d ago.
Quick answers
Why is "Want obesity drugs covered by insurance? Telehealth companies have a big say" trending?
Because 2 independent news sources published 2 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (2)
- Some US employers to drop GLP-1 coverage by 2027 NewsNation · 157d ago
- Want obesity drugs covered by insurance? Telehealth companies have a big say NPR · 157d ago
Topics
Related trends
Five US states join FTC suit against Hims & Hers over privacy practices
Five U.S. states joined the FTC's lawsuit against Hims & Hers on Tuesday, expanding a case that alleges the telehealth company shared sensitive health data with Meta and Snap and charged for prescriptions before provider consultations.
Hers Health, Inc. Reports Third Quarter 2026 Financial Results
Hims & Hers Health reported Q3 2026 revenue of $401.6 million, up 69% year over year, but narrowed its full-year revenue guidance and cut its adjusted EBITDA forecast, sending shares down sharply.
Want to fly to the moon? NASA is looking for new astronauts to help grow its Artemis program
NASA is accepting applications for its next astronaut class through Dec. 3 to support Artemis moon missions and future Mars flights.
“I Want It to Be Horny for All”—On the Set of Hudson Williams’s New Spooky Series Yaga
Entertainment coverage focuses on the release and critical reception of Hudson Williams's new witchcraft-themed series Yaga on AMC+.
Germophobe Primates Want to Avoid Getting Sick, Too
New research reveals that primates alter their feeding habits and avoid contaminated food following viral outbreaks.
Is my GLP-1 safe? What to know about FDA's crackdown on copycat drugs
FDA moves to curb bulk compounding of GLP‑1 weight‑loss drugs as legal action hits telehealth firm HIMS